DatasetName,RPS3_C(104) RPS3_S(104) RPS3_S(209) RPS3_S(224) RPS3_S(240) RPS3_S(83) RPS3_T(113) RPS3_T(220) RPS3_T(237) RPS3_T(242) RPS3_T(7) RPS3_Y(120),RPS3_T(136) RPS3_T(214) RPS3_T(221)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,0.619302915485957
FSO2013_Ratio M/L normalized Rep3,0.46848578527606527,0.6119173638956034
SR2019_MCF7_Biol_repl_3,,0.6137344040906715
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,0.5881830850330448
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.6570201154990322
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.46237692395168634,0.6703500883295143
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.4481109181867235,0.6127150243425763
HS2024_6_B_T3,,
JW2015_Intensity pre1,,0.6093164068538973
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.4710037810471753,0.6031336986821078
SR2019_MDAMB231_Biol_repl_4,,0.622617839684762
GF2025_P2_Sph,,0.6134362510843013
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.6359786070289154
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.47906610910471725,0.6036110660719003
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.6214859234584529
RB2022_5_PreEndurance,,0.6529888562078994
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.4845829394967222,0.6199451816103363
WZ2023_Pu_010_30min,0.4847931915907627,0.7448477125085368
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,0.6604856606555924
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.6800524846019601
RB2022_8_RecoveryEndurance,,0.6760182300767873
KBE2022_Log2_Ex_14_U,0.4812912884286978,0.6183520850019175
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.47155053152795934,0.6810814566918147
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,0.6813277618495022
RB2022_5_PreSprint,,0.6529847859076554
PG2020_Intensity 8h_C,0.4623468677138704,0.6743568898251772
AH2018_SILAC_MR_2_N,,0.6724192380314985
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.6663099396919068
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,0.5654843648251019
FSO2013_Ratio H/L normalized Rep2___2,0.46490711982479754,0.5855591451157608
EP2017_Pervanadate R#3 normalized log2 ratio,0.4706486444719645,0.6121750617761573
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,0.6577443277804599
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,0.661498178623764
GF2025_P6_Sph,,0.6467457712450612
RB2022_2_PreSprint,,0.6550053949713323
ZX2022_CB treated Replicate 3,0.44951429030510087,0.6164057874529706
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.4724956841525538,0.7421462937623019
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,0.6311952133993883
WZ2023_Pu_005_10min,0.47733510222147296,0.7448497838914415
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.6933330061733481
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.47628816202923296,0.7437463762607089
AH2018_SILAC_MR_2_X,,0.678163074646319
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.47786576627114136,0.5915489491396718
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,0.6179139877700487
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.4821985910076367,0.6073851515080624
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.6467922833563472
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.46632604829586816,0.6484600739006465
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5957586540393863
AH2018_LFQ_1_C,,0.6786647687614819
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.6267290282363791
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.4804861792198661,0.7426334041642106
CK2022_11 40-1,,0.6922194784638093
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.4662309667779931,0.6482217074782
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.46161517290411885,0.7320908040332964
FSO2013_Ratio H/L normalized Rep2,0.4644542752164645,0.5957735101511896
WZ2023_Pu_005_20min,0.48266763424070297,0.7421974267637315
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.470920519047048,0.5901809082534776
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.684215041850289
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,0.6338544272245484
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,0.4678366432860397,0.5972772389607295
SR2019_BT549_Biol_repl_3,,0.6133917945803488
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,0.6806794847518945
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.6659367404185713
CK2022_1 200-1,,0.6718016761896765
PG2020_Intensity Mock_10h_D,,0.6560336424747366
SR2019_MCF10A_Biol_repl_2,,0.6185463218052929
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,0.6727702667090772
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4790194202359663,0.646433327312698
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.4750981560948051,0.6325604387541693
PG2020_Intensity 2h_C,,0.628023378309846
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.4511831676480622,0.6168629024981227
KBE2022_Log2_Ex_8_T,0.4817034940916156,0.616960898822637
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.5273767291816263
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.6760307833399025
CK2022_3 40-1,,0.7007608311758095
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.650699660928183
HH2022_Reporter intensity 8,,
ZQ2022_N2,,0.5637490230411553
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.48438391576738904,0.6431461210932296
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.6473198765265519
YA2020_Reporter_intensity_Normal_No.1,,0.644653844637969
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.648179303916447
RB2022_1_PostEndurance,,0.5936988414940354
CR2017_Ratio Replicate 3,0.4709957905155759,0.5924186576161935
SR2019_Hs578T_Biol_repl_3,,0.6034194374330165
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.6132459846413671
HS2024_8_I_T3,,
CF2017_EOC 3,,0.7023919243093665
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,0.6135241542185268
WZ2023_Pu_010_20min,0.47682853076943643,0.7459331619958007
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.7010714152117302
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.6591232776743411
KS2014_Intensity N3,0.48291123210806747,0.7321730096760968
RB2022_4_RecoveryEndurance,,0.6579285843202924
RB2022_5_RecoveryEndurance,,0.6545170474306251
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.4668701113554515,0.6628177984054228
FSO2013_Ratio H/M normalized Rep2,,0.5788501703959675
RAM2015_Log2 A,0.47315764702631063,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.6887881912859418
KS2014_Intensity E15_2,0.4617141174116776,0.7320128078984783
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.6588502945920651
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,0.6647378428225088
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.6471793622109193
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.6211557662814768
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.6652904288671916
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.4847690040176402,0.6201690418582485
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,0.6380881099385459
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.4751726497671231,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.6874062536568505
AH2018_SILAC_IT_3_X,0.46318239404247086,0.6547347985970547
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.4554934263040198,0.6918688439097297
FSO2013_Ratio M/L normalized Rep2,0.450536961902228,0.5972931673579457
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,0.6463803202204748
CK2022_14 40-1,,0.6891064898324452
RB2022_6_PreSprint,,0.672799991711598
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.6530469467290064
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.6664998589281707
DL2023_control-1,,
AR2021_ALG 10 μM,,0.6324662862703918
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.4676477972900577,0.6555238351287426
EJN2021_4_Rest_Ins,,
RN2012_H05,,0.6075771091746794
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5848517062516315
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.6417604923140119
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.46230942374294237,0.6735866790847328
JW2021_After_3,,
GF2025_P8_Sph,,0.6383475541259722
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.46555639853029857,0.6477955322032515
CK2022_11 200-1,,0.6646789677478856
CK2022_12 200-1,,0.6678505690670682
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.4840017634033123,0.7389315263375353
AH2018_TMTMS2_2_N,0.4735707975728857,0.6852589672616319
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.6391747449828372
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.47062679213265374,
AH2018_TMTMS3_Pool,0.48463538896871744,0.6472251250244101
KS2014_Intensity N4,0.4690995638105672,0.7332656801609003
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.6090751259743773
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.7159351513899802
CK2022_14 200-1,,0.6615998009012526
SR2019_Hs578T_Biol_repl_1,,0.6167433508780477
RB2022_7_PostSprint,,0.6401740233620483
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.4853050753914787,0.6661087560909994
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.642917370499747
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,0.6025374681436735
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.6545793388494353
GF2025_P1_Adh,,0.5821374035549822
GF2025_P1_Sph,,0.590401740415124
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.4772502288038258,0.74369047320639
CF2017_EOC 1,,0.7043001873418261
CK2022_3 200-1,,0.6724238868243108
AH2018_LFQ_IT_3_C,0.4636893922711008,0.6515252907336156
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,0.6200260623919581
HS2024_3_B_T2,,
RB2022_6_PreStrength,,0.6339930468316792
CK2022_2 40-1,,0.7007744751092959
RB2022_1_PostSprint,,0.6259213629708373
CK2022_4 200-1,,0.6732261266383467
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.6599537649573185
AR2021_ALG 1 μM,,0.6383676328563709
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,0.6150121119685553
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.4780652022093002,0.6314048063327623
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.6395101739005499
CK2022_9 16-1,,0.6585977979537815
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,0.6567694694729999
CK2022_13 200-1,,0.66441641879516
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.45218600141967064,0.6675238291447716
CK2022_16 16-1,,0.657277865005338
FS2019_db/db3,,0.6366944145711458
CK2022_15 40-1,,0.6900525158335683
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.478992425557584,0.7442609648114461
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.6428069599378438
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.4662647349008527,0.6481388462699176
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.48127443376519263,0.6380343814252395
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.479708936526367,0.6321903372118602
AH2018_LFQ_M_1_N,,0.6832178782091828
KBE2022_Log2_Ex_27_U,,0.6395271960935253
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.4704516198863294,0.6630401230609664
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.6802137632382147
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.6660921357719902
YA2020_Reporter_intensity_Normal_No.4,,0.6450713015722197
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.6497504117176095
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.6593257049338824
RN2012_L13,,0.6003460582962221
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.48469873205888375,0.6583310683971012
SR2019_SKBR3_Biol_repl_3,,0.630639091976713
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5847050828080794
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.6928597975592945
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5534554803377038
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,0.7128285960984942
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,0.6522898340960507
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.6775499282810852
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,0.6116355466935316
AH2018_TMTMS2_3_X,0.47460446049439575,0.6792838228130481
GF2025_P3_Adh,,0.601396622277169
SR2019_JIMT1_Biol_repl_2,,0.6868470633745974
AH2018_TMTMS2_1_C,0.4749558188613808,0.6879203337063299
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.6254201385304138
KBE2022_Log2_Ex_19_U,0.4832122775635341,0.6348203043049127
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,0.6369554134003592
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.6618570097203582
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.4647143770546764,0.5971847743991897
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,0.6453388408280173
RB2022_5_RecoverySprint,,0.5760301760679095
RB2022_7_RecoverySprint,,0.6382247409557634
YA2020_Reporter_intensity_Normal_No.3,,0.6371210807620913
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.6737694629087443
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.48390176592085005,0.7342304934380516
HH2022_Reporter intensity 1,,0.6466783189285147
HH2022_Reporter intensity 2,,0.6465321623027164
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.6482754706907644
SR2019_MCF7_Biol_repl_1,,0.6109002199420289
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.47985173650001706,0.5769591121789222
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,0.7029491062190615
CR2017_Ratio Replicate 2,0.4819736998434465,0.6036359008253669
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.5965575127000101
AR2021_KD 72h,,0.6077512616261176
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.6464328838890766
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.48719579017910203,0.6472907616076863
KBE2022_Log2_Ex_9_U,,0.6256442760589285
AH2018_SILAC_M_3_N,,0.6477583625686189
KBE2022_Log2_Ex_13_T,0.48017625745193343,0.6174473164408077
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,0.6285679591619732
PG2020_Intensity Mock_10h_C,,0.6450874061433874
CF2017_OSE 29,,0.6755978848700085
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,0.6656704387159823
RN2012_L12,,0.5637788443861089
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.648032173167664
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.592665961448026
JW2015_Intensity cap2,,0.5939832407676814
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.6926433664575319
RB2022_7_RecoveryEndurance,,0.6702218163001175
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,0.5682849822089997
KS2014_Intensity pY_PV3,,0.5982753363966585
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.6433928956330831
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.6447116286096509
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.469153697858494,0.7238813346069968
RB2022_1_PreSprint,,0.6387785562647175
HS2024_4_I_N1,,
CK2022_7 200-1,,0.6640315636662097
CK2022_5 200-1,,0.665173537667889
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.596128807465233
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,0.6031357787822641
AH2018_LFQ_2_C,,0.669853860165791
AH2018_SILAC_MR_1_X,,0.6788290504513862
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.6371588231227007
AH2018_SILAC_3_C,,0.6480371538744126
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5881153157653789
CK2022_4 16-1,,0.666806649179061
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,0.6244526038183312
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.6783796461521564
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.641833574329727
FSO2013_Ratio H/L normalized Rep3,0.4701338032837796,0.6017393020614731
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,0.6284773550061481
AH2018_SILAC_IT_2_N,0.46879624083114496,0.6551618366081714
AH2018_SILAC_IT_1_X,0.46141334825318414,0.6581942226424123
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,0.5673551955350612
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.6393681346171173
WZ2023_Pe_025_20min,0.4832956385743423,0.7419213330283264
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.6736954588581772
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.4723044843414143,0.6801604856903447
RN2012_H06,,0.5692154872277336
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.47639789125579585,0.7424962996938845
SR2019_HCC1419_Biol_repl_4,,0.6172216312025571
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.6713366262957502
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.567982975810453
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.47609885021954806,0.587937508353378
WZ2023_Su_025_10min,0.48142891863377457,0.7430325975672343
AH2018_LFQ_IT_4_X,,0.646781337476414
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,0.6045759839988265
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.47169759306440184,0.7434023008421283
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,0.636295403562762
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.4749942976634765,0.6014231041141386
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.4720432091951603,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.46394000473922664,0.6749066173183514
LY2019_P7+,,0.6579493347023556
EP2017_Untreated R#1 normalized log2 ratio,0.48701972283436556,0.6212835051331179
RN2012_L10,,0.5783952584038035
PG2020_Intensity 4h_C,,0.6368162248920445
EP2017_Mitotic R#3 normalized log2 ratio,0.47624680648852397,0.6432807053045728
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.637940641034947
RB2022_8_PostStrength,,0.6310932073918062
AH2018_SILAC_IT_2_X,0.4637446069089848,0.6552160546691715
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,0.6310960030149061
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.48076724163063345,0.5933286504458424
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.6649600900784107
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.48000247912819405,0.6541609671472722
GF2025_P9_Sph,,0.6047331783921294
CK2022_6 200-1,,0.6632284112388832
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.49002751387232163,0.6470416722663646
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,0.6036072499456175
SR2019_HCC1954_Biol_repl_1,,0.6572646489558568
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,0.6222581934810338
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.6420044314702487
PG2020_Intensity 2h_D,,0.6471423756771264
EP2017_Untreated R#3 normalized log2 ratio,0.47185535677477036,0.6452803395659114
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.6637312630908888
KS2014_Intensity pY_C4,,0.6333869181972057
CR2017_Ratio Replicate 3.5,0.47564096749624546,0.6165287360276346
RB2022_7_PostEndurance,,0.5846618289600668
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.4766628292911285,0.6140558680177918
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,0.633679657108991
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.4636243642390705,0.6516640898555357
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,0.6330564340657658
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,0.6182139691041456
AH2018_SILAC_MR_3_N,,0.6763190449578301
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.6739123776701142
PG2020_Intensity CT_C,,0.639817416944228
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,0.6313049423259899
KS2014_Intensity pY_PV4,,0.5940727628248222
KBE2022_Log2_Ex_39_U,,0.6240676949937184
EP2017_Untreated R#3 log2 ratio,0.47195635462634594,0.6456834803366306
RB2022_2_PostStrength,,0.6445384657605299
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.4803289762641092,0.6269336532691497
HS2024_8_PD_T2,,
FS2019_Ctr2,,0.6098045380894764
RB2022_6_PreEndurance,,0.6625994410415603
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.6580926467451822
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.4781824889146313,0.6119103414464394
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5947612079919904
YA2020_Reporter_intensity_Normal_No.2,,0.6365274375966867
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.4702978854831041,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.680143240107092
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.4791489664285809,0.6218307430353015
CK2022_2 16-1,,0.6674715988244451
RAM2015_Log2 B,0.4740995441270249,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.46531608318324524,0.5871949985495517
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,0.5779507145858683
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,0.5913250299804184
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.64037542641255
WZ2023_Su_025_30min,0.471040209148102,0.740897559620571
AH2018_LFQ_4_N,,0.6710167474107358
CR2017_Ratio Replicate 1.2,0.4664135731655518,0.6262329683023763
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,0.6716757746261789
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.4693225153620932,0.664689620122369
RB2022_7_PreEndurance,,0.6180080934395654
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.585677433661145
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.6252621626209748
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,0.6621011415532845
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.4830979303743965,0.6577689600170692
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,0.6657158741132146
KS2014_Intensity C5,0.4696859572347827,0.7244858674291729
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.6105951648946205
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,0.6065408579627443
AH2018_LFQ_M_4_N,,0.6768412944427018
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.45916337026576054,0.6674507980067825
AH2018_LFQ_2_X,,0.6687638274893066
PG2020_Intensity 2h_B,,0.6361838021583991
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,0.6074903765891323
KS2014_Intensity E15_3,0.4678792498229784,0.7259356301818668
GF2025_P3_Sph,,0.6299987172258331
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.4624192252334132,0.6702323640278016
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.45818487747489317,0.5586701757161435
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.4675816383555896,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.4668717545580124,0.6563292527965361
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,0.6133400120555451
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.48520420841338024,0.6363803309911528
ZQ2022_N1,,0.5535164832887928
LY2019_P6-,,0.5551130125667229
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.5778968200311567
JW2015_Intensity pre2,,0.5888290148258898
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5897097088157262
AH2018_LFQ_3_N,,0.6729277125096979
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,0.5739910815595844
KBE2022_Log2_Ex_13_U,0.48125464813217955,0.657059210448573
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,0.6728106083268778
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.6924282865529398
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.6438436470864924
SR2019_BT549_Biol_repl_2,,0.5962080140014533
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,0.6097753337867183
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.4719049198450511,0.740796803796997
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.505302384024936
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.46012462406098975,0.5909905290359733
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.6898645458478184
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.6199322908042488
PG2020_Intensity 10h_D,,0.6706730432714182
RB2022_8_PreEndurance,,0.6347266001301729
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.47148223093352565,0.613127201330924
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,0.6347829515678839
AH2018_SILAC_MR_3_C,,0.6818380494249637
AH2018_LFQ_M_4_C,,0.6731931797607092
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.6080296634117744
CK2022_6 40-1,,0.6924335120431663
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.6440327078661671
LY2019_P3-,,0.5346976423903823
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.477902181501793,0.7444011506687557
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,0.600470581107689
PG2020_Intensity CT_A,,0.6221101490278959
FS2019_Ctr3,,0.6139489434461073
WZ2023_Pu_025_20min,0.4856988370921664,0.7448993315388063
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.6438643986783177
RB2022_1_RecoveryStrength,,0.7018519495737521
SR2019_HCC1954_Biol_repl_4,,0.6400782839829326
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.47439364085345154,0.6827493327949486
RB2022_4_PreSprint,,0.6515908513882186
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.48527908426119115,0.64976911671013
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.46896196241165616,0.6718394431788738
LY2019_P8+,,0.5317273837990653
RB2022_2_RecoveryEndurance,,0.6644067699905953
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,0.6235838028318023
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,0.6157985187661872
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.4718652908313535,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.672040155701484
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.627319367698193
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.6961303213025741
LY2019_P2-,,0.5768331219493023
AH2018_LFQ_IT_1_X,0.46619709262530235,0.6647213963585502
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.6512629526735599
WZ2023_Pe_005_20min,0.4768930958621547,0.7435345310834279
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.7047154496531491
SR2019_MCF10A_Biol_repl_4,,0.6281534138719114
KS2014_Intensity pY_C5,,0.6315339562409441
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.6858725064631287
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.6422361422444012
AH2018_TMTMS3_3_N,0.48403708842268184,0.6507999107564518
SR2019_HCC1419_Biol_repl_2,,0.6123190177860169
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.684430389428019
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.477693656496188,0.6440443426269633
KBE2022_Log2_Ex_36_T,,0.6440337737207752
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.47617003439802685,0.7397952760855565
KS2014_Intensity C2,0.4669719401189381,0.7236970208339111
FSO2013_Ratio H/L normalized Rep1___2,0.46068416730022815,0.5686673350174835
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.6361118679857399
CK2022_9 200-1,,0.6658695176733405
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.6634663882073114
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.654924216456363
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.4838394909040944,0.6437543348650193
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.46083688617257157,0.7175970501771376
ZQ2022_C3,,0.6541535641625844
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.6220942531800804
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.4871459447374329,0.6216793329067357
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.4839352468610893,0.7457340382297225
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,0.6415494613661448
HS2024_5_I_T3,,
KS2014_Intensity N1,0.4685011847472325,0.7254418993945415
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.46694215690937924,0.5971840466701385
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.6769564118463668
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.622659613148951
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.6771529343632715
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5919079475562606
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.6210869591595481
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,0.5762144263720695
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,0.6286183791219336
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.47592473410251546,0.744442463072614
KBE2022_Log2_Ex_29_U,,0.6289373491205154
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.6752196514214711
AH2018_LFQ_IT_4_N,,0.6472783167623631
CK2022_15 200-1,,0.6642090452477044
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.6299489098355076
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.5945329359938618
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.671505827272512
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.47204795787035253,0.740140687767166
RN2012_H01,,0.618831751816156
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,0.6378137039572875
MM2018_Ratio H/L replicate 3,,0.6087662627799104
EP2017_Pervanadate R#1 normalized log2 ratio,0.47431095976872545,0.6005219572196441
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.6609493318534173
KBE2022_Log2_Ex_44_U,,0.6394760399263554
WZ2023_Pe_010_20min,0.47235037904232186,0.7405665671700187
KS2014_Intensity pY_C6,,0.6338095421534778
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.4683865044505899,0.7315352817757447
FSO2013_Ratio H/M normalized Rep3___1,,0.5969468733966333
AH2018_SILAC_M_3_C,,0.6489076627044436
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.46433860604820915,0.6518553310113154
AH2018_SILAC_M_2_X,0.4659034843032111,0.6463827581276321
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.650348702245439
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.47293806440666303,0.738591023558577
PG2020_Intensity 6h_C,0.4562077613098085,0.6536159362544115
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.6789498980082119
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.4730818964910615,0.6788848048660902
CK2022_15 16-1,,0.6560531206129246
CK2022_3 16-1,,0.6648687998447801
LY2019_P4-,,0.6036745426066132
FSO2013_Ratio H/L normalized Rep3___2,0.47110384549477313,0.6103460477956634
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.6113491093469726
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5720335093551995
CK2022_10 16-1,,0.6605048649000724
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.47734542330734614,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.5639589172811196
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4806217073768558,0.6538191349705021
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.6925860607530071
AR2021_L41 10 μM,,0.6327598468111343
CF2017_EOC 2,,0.7028842000258217
RB2022_6_PostEndurance,,0.6538582309970619
AH2018_SILAC_1_N,0.46686561343034955,0.6627019036414347
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.5648957903736097
RB2022_7_PreSprint,,0.6552170182670559
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.6591232776743411
ZX2022_CB treated Replicate 1,0.4517318578520853,0.6164156232525103
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.6464469856688582
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,0.6346931134910022
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.4736532216540608,0.6828418203000152
AR2021_L41 1 μM,,0.6303289790999823
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.4754988372205142,0.6868546702087261
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.4501359990607942,0.6122961910914534
KS2014_Intensity C4,0.47218243401728505,0.7192694494894917
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.6324417192972124
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,0.6396266176116092
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.6799930698991413
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.6603867128911186
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.6543698696786678
AH2018_SILAC_IT_3_C,0.46566291750915595,0.6643359886087289
WZ2023_Pu_025_10min,0.47761474061965026,0.7448389015638185
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.47393073690122683,0.6111852871353901
SR2019_JIMT1_Biol_repl_4,,0.6631762163236145
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.7034288822834821
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.4776049470551007,0.7426616477304472
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.4655607164669478,0.6477169702426733
KS2014_Intensity C6,0.44715121152772525,0.7322478194509062
ZQ2022_N3,,0.5616451085359864
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.695954828706059
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.4525157795076226,0.6168631130441197
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.6902358479707175
AH2018_SILAC_IT_2_C,0.46506742342243723,0.6662655038602954
CK2022_5 40-1,,0.6930749563892326
AH2018_LFQ_3_X,,0.6744531967446602
UK2020_UA_3,,0.572552252687152
LY2019_P7-,,0.6462040543131448
GF2025_P5_Adh,,0.5855176707657854
RB2022_1_PostStrength,,0.6462308334561194
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.6023336368747777
SR2019_HCC1954_Biol_repl_3,,0.6423882615820725
CR2017_Ratio Replicate 2.2,0.4812813677912205,0.6120692765685887
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.6563773981138568
ZQ2022_C1,,0.6670339599351777
CR2017_Ratio Replicate 2.1,0.4946889209758258,0.6238165761283884
PG2020_Intensity CT_B,,0.6404081662621663
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.6735217589743955
KS2014_Intensity pY_E5_1,,0.6403396776753979
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,0.6317536961126096
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.6732256419944616
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.680547756645569
YA2020_Reporter_intensity_Cancer_No.4,,0.653388181816756
KS2014_Intensity pY_E5_2,,0.6386720569918491
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.6263065339569778
RB2022_2_PreEndurance,,0.6590803777862541
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.6380689231215254
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.6567190226114784
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.4771754185666884,0.6580677476941267
KS2014_Intensity pY_N1,,0.6426895080469387
RB2022_1_RecoveryEndurance,,0.6374952611849881
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.47930968135322094,0.6463719549689984
AH2018_TMTMS2_1_X,0.4744635376996591,0.68772119059736
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,0.6127463557867838
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.6986297590032349
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.4661928511603395,0.664631592049973
PG2020_Intensity 10h_B,,0.6750308461227622
AH2018_TMTMS3_1_X,0.4868084673316945,0.6592617411494427
CF2017_FTE 14,,0.6791656803433089
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.46101025630488995,0.6609487273565939
SR2019_HCC1419_Biol_repl_3,,0.6126345755578116
KBE2022_Log2_Ex_14_T,0.4812608207493827,0.6207756847841529
EP2017_Untreated R#2 normalized log2 ratio,0.4797725120543259,0.5769489354159051
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.6971865802336953
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.4774343645718182,0.6151071108907483
AS2011_Ratio H/L Normalized RNAi_2_1,,
